Skip to content

ELITE-ROW

Evaluation of Lifetime participation in Intensive Top-level sports and Exercise - Rower’s Aortic Widening - AORTA-ROW

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON57995
Enrollment
200
Registered
2025-03-07
Start date
2025-10-21
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aorta, aortic dilation, aortic dilatation, aortic root, aortic ascendens, aortic measurements, sports heart

Interventions

Not applicable.

Sponsors

Amsterdam UMC
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Aged 40 years and older, both male and female Former elite rower, defined as at least 10 years of participation at a high national, international, or Olympic level of rowing Participating in ELITE-ROW-screening 

Exclusion criteria

Exclusion criteria: Unable to give informed consent Any evidence of a heritable connective tissue disorder associated with thoracic aortic disease, such as Marfan syndrome, Loeys-Dietz syndrome or other genetically confirmed forms of familial thoracic aortic aneurysm and dissection (FTAAD). Participants with a family history of a known pathogenic variant of a connective tissue disorder who have undergone genetic testing and are confirmed not to carry the familial mutation will not be excluded

Design outcomes

Primary

MeasureTime frame
Investigate the prevalence of aortic mortality, surgery, and pathology, in former national, international or Olympic rowers who participated between 1964 and 1984Determine the prevalence of aortic dilatation in former elite rowers with at least 10 years of competition at the national, international, or Olympic levelEvaluate aortic MRI-derived properties (3D aortic displacement, OSI, and PWV) in former elite rowers with versus without aortic dilatationEvaluate aortic MRI-derived properties (3D aortic displacement, OSI, and PWV) in former elite rowers with dilated aortas versus patients with pathological Marfan aortas

Secondary

MeasureTime frame
Identify rower characteristics associated with aortic dilatationAssess levels of uncertainty intolerance of, optimism, and health anxiety in former elite rowers with a dilated aortaInvestigate coping strategies of former elite rowers to manage health-related uncertaintiesIdentify factors associated with high uncertainty intolerance in former elite rowers with a dilated aorta

Countries

Netherlands

Contacts

Public ContactH El Hri

Amsterdam UMC

h.elhri@amsterdamumc.nl0640994680

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: May 22, 2026